Depression and failure of cholesterol lowering after acute myocardial infarction

Jeff C Huffman1, Felicia A Smith, Gregory L Fricchione

  • 1Department of Psychiatry and Department of Cardiology , Massachusetts General Hospital and Harvard Medical School , Boston.

Insights

Depression following myocardial infarction (MI) hinders cholesterol reduction. Early post-MI depression was linked to significantly less improvement in lipid levels six months after the event.

Area of Science:

  • Cardiology
  • Psychiatry
  • Preventive Medicine

Background:

  • Depression after acute myocardial infarction (MI) is linked to higher cardiac mortality.
  • The mechanism behind this association is not fully understood.
  • The impact of post-MI depression on lipid-lowering therapy, a key secondary prevention strategy, has not been previously studied.

Purpose of the Study:

  • To investigate the association between early post-MI depression and cholesterol reduction six months after MI.
  • To test the hypothesis that patients with early post-MI depression exhibit inferior cholesterol reduction compared to non-depressed patients.

Main Methods:

  • A prospective observational cohort pilot study enrolled patients within 72 hours of MI.
  • Depression was assessed two weeks post-MI using the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID) for major depressive disorder (MDD) and the Beck Depression Inventory-II (BDI-II).
  • Cholesterol levels were measured six months post-MI.

Main Results:

  • Seventy subjects with available depression assessments and cholesterol data were analyzed.
  • Post-MI depression, identified by both MDD interview and BDI-II, was associated with significantly poorer cholesterol reduction (8 mg/dL improvement in depressed vs. 37 mg/dL in non-depressed).
  • Linear regression confirmed that depression (MDD and BDI-II) independently predicted smaller cholesterol reductions, even after accounting for demographic and medical variables (beta=-.301, P<.001 for MDD; beta=-.269, P=.001 for BDI-II).

Conclusions:

  • Early depression following myocardial infarction is independently associated with impaired lipid lowering.
  • These findings suggest that depression may interfere with secondary prevention efforts in post-MI patients.
  • Further research is warranted to explore the mechanisms and clinical implications of this association.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...